Evaluation of Two Different Designs of Bausch & Lomb Contact Lenses
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-05-06
- Last Posted Date
- 2020-10-06
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 376
- Registration Number
- NCT01118338
- Locations
- 🇺🇸
Bausch & Lomb, Rochester, New York, United States
Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge
- First Posted Date
- 2010-04-21
- Last Posted Date
- 2012-03-21
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 101
- Registration Number
- NCT01107405
- Locations
- 🇺🇸
Bausch & Lomb, Rochester, New York, United States
Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2012-01-13
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 407
- Registration Number
- NCT01060072
- Locations
- 🇺🇸
Bausch & Lomb, Rochester, New York, United States
Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2019-06-21
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 98
- Registration Number
- NCT01060787
- Locations
- 🇺🇸
Ophthalmic Partners of Boston, Boston, Massachusetts, United States
Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-12-09
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 357
- Registration Number
- NCT01028027
- Locations
- 🇸🇬
Bausch & Lomb Inc, Singapore, Singapore
A Study to Evaluate the Clinical Performance of a Novel Multipurpose Solution
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2011-08-15
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 312
- Registration Number
- NCT01024751
- Locations
- 🇺🇸
Bausch & Lomb, Rochester, New York, United States
Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-11-10
- Last Posted Date
- 2012-01-09
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 406
- Registration Number
- NCT01010633
- Locations
- 🇺🇸
Bausch & Lomb, Inc., Rochester, New York, United States
Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-09-28
- Last Posted Date
- 2015-03-24
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 272
- Registration Number
- NCT00985231
- Locations
- 🇺🇸
Bausch & Lomb, Rochester, New York, United States
Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-09-09
- Last Posted Date
- 2012-03-29
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 474
- Registration Number
- NCT00972777
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States
Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-21
- Last Posted Date
- 2011-12-09
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 119
- Registration Number
- NCT00905762
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States
© Copyright 2024. All Rights Reserved by MedPath